Home・Lista de Ações・Novartis AG

Novartis AG

Fechado

154.54 -1.7

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

154.09

Máximo

157.22

Indicadores-chave
By Trading Economics
Rendimento	110M 3.3B
Vendas	894M 14B
P/E Médio do Setor	23.979 57.366
EPS	2.41
Rendimento de Dividendos	2.98
Margem de lucro	22.654
Funcionários	75,267
EBITDA	526M 5.9B

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+0.93% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	2.98% 2.16%

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	15B 300B
Abertura anterior	156.24
Fecho anterior	154.54

Novartis AG Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

26 de ago. de 2026, 23:56 UTC

Fluence Energy Inc shares are higher in after-market trading. Broader market context includes recent PCE price index data indicating ongoing inflationary pressures.

26 de ago. de 2026, 23:56 UTC

Correlated Moves

Social Media

Tesla shares are trading higher in after-market hours, supported by increased institutional holdings from major investors and a broader market uptick.

26 de ago. de 2026, 23:56 UTC

Shares of Stanley Black & Decker Inc rose modestly in after-market trading, settling at a cumulative return of 0.33% since Wednesday's close.

26 de ago. de 2026, 23:56 UTC

Shares of Synchrony Financial are lower in after-market trading, moving from an early high to a low during the session.

26 de ago. de 2026, 23:56 UTC

RTX Corp. shares are trading lower in after-market hours, with significant volatility noted since Wednesday's close and prices below the 20-day moving average.

26 de ago. de 2026, 23:56 UTC

Macro Event

EUR/AUD trades lower as Australia's July inflation rate declines to 3.5%, exceeding expectations. The currency pair remains near the lower end of its one-month range.

26 de ago. de 2026, 23:56 UTC

Ralph Lauren Corp shares are lower in after-market hours, continuing a trend from regular trading. The stock remains below its 20-day moving average.

26 de ago. de 2026, 23:56 UTC

News

Constellation Brands reported first-quarter results that beat expectations, driven by beer sales. The company also reaffirmed EPS guidance and plans a $100 million investment.

26 de ago. de 2026, 23:56 UTC

Cheniere Energy shares are trading lower in after-market hours. No specific news was identified to explain this price movement.

26 de ago. de 2026, 23:52 UTC

AT&T Inc shares are lower in after-market hours with no specific news identified. Broader market data on rising consumer prices may influence investor sentiment.

26 de ago. de 2026, 23:52 UTC

MARA Holdings Inc. shares are higher in after-market hours, supported by robust economic data and easing crude oil prices, reflecting a positive market trend.

26 de ago. de 2026, 23:52 UTC

Correlated Moves

The SGD/CHF is trading higher, supported by a recent rise in USD/CHF. It remains near the upper end of its one-month trading range.

26 de ago. de 2026, 23:52 UTC

The Swiss franc is trading lower against the South African rand during Wednesday's session, remaining near the lower end of its one-month range.

26 de ago. de 2026, 23:51 UTC

The Nikkei 225 Index is trading higher in after-market hours, continuing a trend of upward movement following Wednesday's close.

26 de ago. de 2026, 23:51 UTC

Ladder Capital Corp shares are higher in after-market trading, moving up from earlier lows and trading above its 20-day moving average. No specific news identified.

26 de ago. de 2026, 23:51 UTC

Correlated Moves

Alpha and Omega Semiconductor rises in after-hours trading, recovering from an earlier dip. The stock advanced sharply since Wednesday's close, tracking semiconductor sector gains.

26 de ago. de 2026, 23:51 UTC

Correlated Moves

PagerDuty Inc. shares are higher in after-market hours, driven by strong overall market momentum and Salesforce Inc.'s significant gain. Positive economic data supports this trend.

26 de ago. de 2026, 23:51 UTC

Cabaletta Bio Inc shares are lower in after-market trading, following a decline earlier in the session. No specific news was identified to explain the movement.

26 de ago. de 2026, 23:51 UTC

JetBlue Airways Corp shares are higher in after-market trading, reflecting broader market gains amid positive economic data on consumer prices and durable goods orders.

26 de ago. de 2026, 23:51 UTC

Community Financial System Inc shares are higher in after-market hours, recovering from earlier lows. The stock remains below its 20-day moving average.

26 de ago. de 2026, 23:51 UTC

Beam Therapeutics Inc shares are higher in after-market hours, reflecting a broadly positive market trend. The stock is near the upper end of its one-month range.

26 de ago. de 2026, 23:51 UTC

Arbor Realty Trust is trading higher in after-market hours, advancing from Wednesday's close. Shares earlier pulled back but remain above the prior close.

26 de ago. de 2026, 23:51 UTC

Yelp Inc shares are higher in after-market trading, recovering from an earlier dip. The stock remains below its 20-day moving average.

26 de ago. de 2026, 23:51 UTC

PENN Entertainment Inc. shares rose in after-market trading, gaining modestly since Wednesday's close despite remaining below its 20-day moving average.

26 de ago. de 2026, 23:51 UTC

U.S. markets gain momentum as inflation data reveals slight consumer price rise, while UK car production declines and copper prices surge amid strong demand.

26 de ago. de 2026, 23:51 UTC

U.S. equity indices rise amid positive global sentiment and inflation data, while investors await Nvidia earnings and navigate geopolitical tensions affecting oil prices.

26 de ago. de 2026, 23:51 UTC

Asia equity markets rise on falling crude oil prices and tech stock gains, while caution prevails ahead of U.S. inflation data and Fed Chair's speech.

26 de ago. de 2026, 23:51 UTC

Mixed trading in European equities as easing inflation concerns clash with rising energy prices and UK economic woes.

26 de ago. de 2026, 23:51 UTC

Brazil's Q2 GDP Growth Rate Expected to Rise by 0.8% Amidst Global Economic Challenges, Following a Strong 1.1% Expansion in Q1

26 de ago. de 2026, 23:51 UTC

Market Cautiously Awaits Insights from Jackson Hole Symposium as Inflation Concerns and Fed Dissent Shape Economic Outlook.

Comparação entre Pares

Variação de preço

Novartis AG Previsão

Preço-alvo

By TipRanks

0.93% parte superior

Previsão para 12 meses

Média 159 USD 0.93%

Máximo 180 USD

Mínimo 139 USD

Com base em 5 analistas de Wall Street que oferecem metas de preço de 12 meses para Novartis AG - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

5 ratings

Comprar

Manter

Vender

Com base em 5 analistas que deram avaliações de ações para Novartis AG - Dist nos últimos 3 meses.

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. The company has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. It also has a research collaboration and license agreement with Schrödinger, Inc. to identify and develop various therapeutic candidates; and a strategic collaboration with Vyriad, Inc. for the discovery and development for vivo chimeric antigen receptor T-cell therapies. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.